Listen: Is 23andMe Trading Your DNA? With Maria Liu from First Health Advisory Solutions

 

23andMe, the genetic testing company, just announced that it will be entering a 4-year partnership with pharmaceutical giant GlaxoSmithKline (GSK) to develop new drugs and therapies.

As part of the partnership, 23andMe will share voluntarily-shared genetic data with the big pharma company. Maria Liu from First Health Advisory Solutions joined us to talk about the security concerns and potential worries that come with companies sharing medical data.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!
Twitter – @HealthMKSL
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Latest

US School Districts Are Spending More as Stimulus Deadline Looms
August 15, 2022
(Bloomberg) -- Buoyed by a historic influx of federal pandemic stimulus, the largest school districts in the US are spending more. On average, school district expenses rose 5.4% in fiscal 2023 from a year Read more
Hiring Talent
The Challenges Employers Face in Attracting and Hiring Talent Today
August 15, 2022
Attracting and hiring talent is never easy; it is not an endeavor to be taken lightly. But one would be hard-pressed to find an environment where attracting and hiring the right person for an organization was as Read more
Coverage for Preventative Healthcare Hangs in the Balance
August 15, 2022
A court ruling in Texas could remove the mandate for insurance companies to provide free preventative healthcare. Clearsurance.com’s health insurance expert, Melanie Musson, explains how data analysis can help Read more